Vericel Corporation/ US92346J1088 /
| 2024-04-15 10:00:00 PM | Chg. +0.8000 | Volume | Bid2:31:50 PM | Ask2:31:50 PM | High | Low |
|---|---|---|---|---|---|---|
| 48.7000USD | +1.67% | 352,368 Turnover: 11.58 mill. |
44.1400Bid Size: 200 | 49.0000Ask Size: 100 | 49.2350 | 47.9000 |
GlobeNewswire
02-29
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Fina...
GlobeNewswire
02-27
Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024
GlobeNewswire
02-15
Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024
GlobeNewswire
02-05
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
GlobeNewswire
01-09
Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results
GlobeNewswire
01-09
MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include P...
GlobeNewswire
01-03
Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 20...
GlobeNewswire
2023-12-28
MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for...
GlobeNewswire
2023-11-21
MediWound Reports Third Quarter 2023 Financial Results and Provides Company Update
GlobeNewswire
2023-11-08
Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
GlobeNewswire
2023-09-28
Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of...
GlobeNewswire
2023-09-21
MediWound Announces U.S. Commercial Availability of NexoBrid® for the Treatment of Severe Thermal Bu...
GlobeNewswire
2023-09-20
Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of S...
GlobeNewswire
2023-09-06
Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors
GlobeNewswire
2023-08-15
MediWound Reports Second Quarter 2023 Financial Results and Provides Company Update
GlobeNewswire
2022-03-15
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on March 22, 2022
GlobeNewswire
2022-03-01
Vericel to Present at the Cowen 42nd Annual Health Care Conference on March 9, 2022
GlobeNewswire
2022-02-24
Vericel Announces Appointment of Jonathan Siegal as Principal Accounting Officer
GlobeNewswire
2022-02-24
Vericel Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Full-Year 2022 Fina...
GlobeNewswire
2022-02-10
MediWound Announces Additional $9 Million in Funding from BARDA to Support NexoBrid BLA Resubmission...
GlobeNewswire
2022-02-02
Vericel Announces Plans for a New State-of-the-Art Cell Therapy Manufacturing Facility to Support Lo...
GlobeNewswire
2022-01-25
David Hoffman Joins Delcath Systems, Inc. as General Counsel and Corporate Secretary
